HP-3070: Phase I started

Hisamitsu's Noven Pharmaceuticals Inc. subsidiary began a U.S. Phase I trial to evaluate HP-3070 in patients with schizophrenia. Hisamitsu plans to start a U.S. Phase II trial of the product in its f...